In this free webinar, gain practical insights into the formulation and scale-up of biodegradable lipid nanoparticles (LNPs) for mRNA delivery. Attendees will learn how each lipid in an LNP formulation contributes to its potency, tolerability and manufacturability. The featured speakers will discuss formulation and process design principles that enable both early-stage efficacy and commercial scalability. The speakers will also share how upstream mixing parameters can be fine-tuned to preserve critical quality attributes during scale-up.
TORONTO, May 21, 2025 /PRNewswire-PRWeb/ -- This webinar will introduce participants to the challenges and considerations in development and scale-up of mRNA lipid nanoparticles (LNPs) composed of biodegradable lipids. Attendees will learn the role of individual lipid components in formulation design and strategies to maximize impact on potency, tolerability and scalability for commercial success. Subsequently, a case study will be presented highlighting the scale-up of an LNP formulation, including upstream microfluidic mixing optimization and downstream processing via tangential flow filtration (TFF).
Lipid nanoparticles (LNPs) are the leading non-viral delivery system and are being developed for the treatment of a wide range of diseases and genetic conditions. During the preclinical development phase, LNP formulations are optimized for potency and safety based on the target disease indication and route of administration. To support the early stages of development, small-scale LNP batches are often fabricated using microfluidics and downstream processing via dialysis and ultrafiltration. These small-scale unit operations are material sparing, efficient and yield high-quality LNPs.
Upon selection of a lead formulation, a critical next step towards investigational new drug (IND)-enabling studies involves scaling up the LNP fabrication process, including upstream mixing and downstream purification processes. Microfluidic and turbulent mixing options are available for the upstream unit operation, whereas TFF is commonly utilized for downstream purification and product concentration. During scale-up, the LNP critical quality attributes must be maintained, including particle size, PDI and cargo encapsulation efficiency.
Register for the webinar to gain practical insights into the formulation and scale-up of biodegradable lipid nanoparticles for mRNA delivery.
Join Syed Reza, MD-PhD, Licensing and External Innovation Alliance Management, Drug Delivery Solutions, NOF Corporation; and Nicholas Boylan, PhD, Sr. Director, Scientific Services, Phosphorex, for the live webinar on Tuesday, June 3, 2025, at 12pm EDT (5pm BST).
For more information, or to register for this event, visit From Bench to Scale: Scaling Biodegradable mRNA Lipid Nanoparticle for Clinical Success.
ABOUT XTALKS
Xtalks, powered by Honeycomb Worldwide Inc., is a leading provider of educational webinars and digital content to the global life science, food, healthcare and medical device communities. Every year, thousands of industry practitioners (from pharmaceutical, biotechnology, food, healthcare and medical device companies, private & academic research institutions, healthcare centers, etc.) turn to Xtalks for access to quality content. Xtalks helps professionals stay current with industry developments, regulations and jobs. Xtalks webinars also provide perspectives on key issues from top industry thought leaders and service providers.
To learn more about Xtalks visit https://xtalks.com
For information about hosting a webinar visit https://xtalks.com/why-host-a-webinar/
Contact:
Vera Kovacevic
Tel: +1 (416) 977-6555 x371
Email: [email protected]
Media Contact
Vera Kovacevic, Xtalks, +1 (416) 977-6555 x371, [email protected], www.xtalks.com
SOURCE Xtalks
Share this article